Although PTX3 represents a novel acute‐phase reactant produced at sites of active vasculitis and correlates with disease activity (Ramirez et al., 2019), the vasopathology of SAO is completely different from that of vasculitis. The gene discussed is PTX3; the disease is vasculitis.